Professional Documents
Culture Documents
HYPOTHESIS MINI-REVIEW [These are paper types. Please choose one and delete the rest.]
Short running header [This is a summary of the manuscript title and should only be six to ten words]
[First author] et al
Author name2
1
Author affiliations Departement of Neurosurgery, Faculty of Medicine DR. Cipto Mangunkusumo National
Abstract
Background: butterfly glioblastoma defined as the initial presentation of a grade IV
astrocytoma with contiguous enhancement in bilateral cerebral hemispheres most
commonly spread via eloquent area such us corpus callosum. Because anatomical
involvement and the location as the limiting factor, surgical treatment is more challenging.
Methods: Sample were taken by consecutive sampling method, in which all patients with complete medical
record diagnosed by Glioblastoma and astrocytoma (WHO Grade I-IV) in Neurosurgery Departement of DR.
Cipto Mangunkusumo National Center Hospital from 2015 - 2018 to complete this descriptive study.
1
Results: Glioblastoma is the most common glial cell tumors (70,4%).
Conclusion:
Keywords: [Choose four to six keywords. They should not repeat words given in the title.]
Fundings: State in a table for the funding sources (if there is any)
Introduction
Glioblastoma multiforme is an extremely aggressive diffuse astrocytic tumor commonly found in the
supratentorial white matter of the cerebral hemispheres. It is the most common primary brain tumor in adults,
accounting for 25% of all cases. Glioblastomas most commonly spread via direct extension along white
matter tracts, including the corpus callosum, although hematogenous, subependymal, and cerebrospinal
fluid spread can also be seen. On MR imaging, these tumors typically enhance solidly and intensely in the
corpus callosum, although occasionally no enhancement is seen. Because the corpus callosum is relatively
resistant to infiltration, glioblastoma multiforme should be considered for any lesion crossing the corpus
callosum.1 Bourekas EC, Varakis K, Bruns D, Christoforidis GA, Baujan M, Slone HW, Kehagias D. Lesions of the
corpus callosum: MR imaging and differential considerations in adults and children. American Journal of
Theris no sufficient data about butterfly glioma study, but Dziurzynski K et. al reported 792 patients with a new
diagnosis of glioblastoma, twenty-three patients (2.9 %) were identified that met researcher criteria of butterfly
glioblastoma.2 Dziurzynski K, Blas-Boria D, Suki D, Cahill DP, Prabhu SS, Puduvalli V, Levine N. Butterfly
glioblastomas: a retrospective review and qualitative assessment of outcomes. Journal of neuro-oncology. 2012 Sep
1;109(3):555-63
2
[Generally each major section of your manuscript should have a heading. The most common breakdown of a
paper is given below, with some subheadings related to the above example text. Please delete or include as
needed.]
Sample were taken by consecutive sampling method, in which all patients with complete medical record
diagnosed by Glioblastoma and astrocytoma (WHO Grade I-IV) in Neurosurgery Departement of DR. Cipto
Mangunkusumo National Center Hospital from 2015 - 2018 to complete this descriptive study.
Data were extracted secondarily from medical records. Variables in this study were: sex, age group,
symptoms, duration of symptoms, histopathology report, and the surgical procedure. Radiologic
characteristic we tested including location, lobus involvement, corpus callosum extension (genu, corpus, and
splenium), compression of lateral ventricle, and butterfly appearance. The radiologic characteristic was
any of them, the decision was made by further discussion and agreement. All data were analyzed and
Results
There were 27 samples of total Glioblastoma and Astrocytoma (WHO Grade I - IV) in this study. 19 sample
(70,4 %) was confirmed Glioblastoma Figure 1. (WHO Grade IV). Subjects characteristic and radiologic
3
Discussion
Conclusion
Acknowledgments
Disclosure
The author reports no conflicts of interest in this work. [Each manuscript needs to include a disclosure of
financial interest or other conflict of interest statement. This is where these statements go].
References
1. Burnier M, Fricker AF, Hayoz D, et al. Pharmacokinetic and pharmacodynamic effects of YM087, a
combined V1/V2 vasopressin receptor antagonist in normal subjects. Eur J Clin Pharmacol.
1999;55:633–637.
3. Fried LF, Palevsky PM. Hyponatremia and hypernatremia. Med Clin North Am. 1997;81:585–609.
4. Gheorghiade M, Konstam MA, Burnett JC Jr, et al; Efficacy of Vasopressin Antagonism in Heart
Failure Outcome Study With Tolvaptan (EVEREST) Investigators. Short term clinical effects of
tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST
4
Clinical Status Trials. JAMA. 2007;297:1332–1343.
5. Vaprisol (conivaptan HCl injection) [package insert]. Deerfield IL: Astellas Tokai Co.; February 2006.
5
Table 1 [Table titles are in sentence case and do not end with a full-stop.]
Notes:
Abbreviations: AUC, area under the curve; LS, least squares; NE, not estimable. [These are examples of
format.]
6
Figure 1 [Title of figure is in sentence case and ends in a full stop.]
[Insert figure here if it is small enough. If large (1MB or more) please send in a separate Word
document/PDF/.jpg file.]